Miguel Blanquer Blanquer

Dr. Miguel Blanquer Blanquer

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2011 in International Endodontic Journal
Verified
Journal Article
Closed access
PDF file
FRF. J. Rodríguez-Lozano
F. J. Rodríguez-Lozano
CBC. Bueno
C. Bueno
CIC. L. Insausti
C. L. Insausti
LMLuis Meseguer-Olmo
Luis Meseguer-Olmo
MRM. C. Ramírez
M. C. Ramírez
Jose M MoraledaJose M Moraleda
Jose M Moraleda

15 May 2012 in Stem Cells
Verified
Journal Article
Open access
PDF file
MBMiguel Blanquer Blanquer
Miguel Blanquer Blanquer
Jose M MoraledaJose M Moraleda
Jose M Moraleda
FIFrancisca Iniesta
Francisca Iniesta
JGJoaquín Gómez-Espuch
Joaquín Gómez-Espuch
JMJosé Meca-Lallana
José Meca-Lallana
Raquel Garcia LopezRaquel Garcia Lopez
Raquel Garcia Lopez
The objective of this article is to assess the safety of intraspinal infusion of autologous bone marrow mononuclear cells (BMNCs) and, ultimately, to look for histopathological signs of cellular neurotrophism in amyotrophic lateral sclerosis (ALS) patients. We conducted an open single arm phase I trial. After 6 months observation, autologous BMNCs were infused into the posterior spinal cord funiculus. Safety was the primary endpoint and was defined as the absence of serious transplant-related adverse events. In addition, forced vital capacity (FVC), ALS-functional rating scale (ALS-FRS), Medical Research Council scale for assessment of muscle power (MRC), and Norris scales were assessed 6 and 3 months prior to the transplant and quarterly afterward for 1 year. Pathological studies were performed in case of death. Eleven patients were included. We did not observe any severe transplant-related adverse event, but there were 43 nonsevere events. Twenty-two (51%) resolved in ≤2 weeks and only four were still present at the end of follow-up. All were common terminology criteria for adverse events grade ≤2. No acceleration in the rate of decline of FVC, ALS-FRS, Norris, or MRC scales was observed. Four patients died on days 359, 378, 808, and 1,058 post-transplant for reasons unrelated to the procedure. Spinal cord pathological analysis showed a greater number of motoneurons in the treated segments compared with the untreated segments (4.2 ± 0.8 motoneurons per section [mns per sect] and 0.9 ± 0.3 mns per sect, respectively). In the treated segments, motoneurons were surrounded by CD90+ cells and did not show degenerative ubiquitin deposits. This clinical trial confirms not only the safety of intraspinal infusion of autologous BMNC in ALS patients but also provides evidence strongly suggesting their neurotrophic activity. Disclosure of potential conflicts of interest is found at the end of this article.

1 July 2010 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
CICarmen L. Insausti
Carmen L. Insausti
AAAntonia Alcaraz
Antonia Alcaraz
EGEva M. García‐Vizcaíno
Eva M. García‐Vizcaíno
AMAnna Mrowiec
Anna Mrowiec
CLCarlos Lopez-Martinez
Carlos Lopez-Martinez
FNFrancisco J. Nicolás
Francisco J. Nicolás

1 March 2014 in Stem Cells and Cloning: Advances and Applications
Verified
Journal Article
Open access
CICarmen L Insausti
Carmen L Insausti
MBMiguel Blanquer Blanquer
Miguel Blanquer Blanquer
AGAna M García-Hernández
Ana M García-Hernández
GCGregorio Castellanos
Gregorio Castellanos
JMJosé María Moraleda
José María Moraleda
Epithelial and mesenchymal cells isolated from the amniotic membrane (AM) possess stem cell characteristics, differentiation potential toward lineages of different germ layers, and immunomodulatory properties. While their expansion and differentiation potential have been well studied and characterized, knowledge about their immunomodulatory properties and the mechanisms involved is still incomplete. These mechanisms have been evaluated on various target cells of the innate and the adaptive system and in animal models of different inflammatory diseases. Some results have evidenced that the immunomodulatory effect of AM-derived cells is dependent on cell-cell contact, but many of them have demonstrated that these properties are mediated through the secretion of suppressive molecules. In this review, we present an update on the described immunomodulatory properties of the derived amniotic cells and some of the proposed involved mechanisms. Furthermore, we describe some assays in animal models of different inflammatory diseases which reveal the potential use of these cells to treat such diseases.

1 January 2012 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Francisco Javier Rodríguez-LozanoFrancisco Javier Rodríguez-Lozano
Francisco Javier Rodríguez-Lozano
CICl. Insausti
Cl. Insausti
FIF. Iniesta
F. Iniesta
MBMiguel Blanquer Blanquer
Miguel Blanquer Blanquer
MRMc. Ramírez
Mc. Ramírez
JMJm. Moraleda
Jm. Moraleda
In the last decade, tissue engineering is a field that has been suffering an enormous expansion in the regenerative medicine and dentistry. The use of cells as mesenchymal dental stem cells of easy access for dentist and oral surgeon, immunosuppressive properties, high proliferation and capacity to differentiate into odontoblasts, cementoblasts, osteoblasts and other cells implicated in the teeth, suppose a good perspective of future in the clinical dentistry. However, is necessary advance in the known of growth factors and signalling molecules implicated in tooth development and regeneration of different structures of teeth. Furthermore, these cells need a fabulous scaffold that facility their integration, differentiation, matrix synthesis and promote multiple specific interactions between cells. In this review, we give a brief description of tooth development and anatomy, definition and classification of stem cells, with special attention of mesenchymal stem cells, commonly used in the cellular therapy for their trasdifferentiation ability, non ethical problems and acceptable results in preliminary clinical trials. In terms of tissue engineering, we provide an overview of different types of mesenchymal stem cells that have been isolated from teeth, including dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHEDs), periodontal ligament stem cells (PDLSCs), dental follicle progenitor stem cells (DFPCs), and stem cells from apical papilla (SCAPs), growth factors implicated in regeneration teeth and types of scaffolds for dental tissue regeneration.

2 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JMJose E. Millán-Rivero
Jose E. Millán-Rivero
FNFrancisco M Nadal-Nicolas
Francisco M Nadal-Nicolas
DGDavid García-Bernal
David García-Bernal
PSPaloma Sobrado-Calvo
Paloma Sobrado-Calvo
MBMiguel Blanquer Blanquer
Miguel Blanquer Blanquer
MAMarta Agudo-Barriuso
Marta Agudo-Barriuso
Mesenchymal stem cell (MSC) transplantation is emerging as an ideal tool to restore the wounded central nervous system (CNS). MSCs isolated from extra-embryonic tissues have some advantages compared to MSCs derived from adult ones, such as an improved proliferative capacity, life span, differentiation potential and immunomodulatory properties. In addition, they are more immunoprivileged, reducing the probability of being rejected by the recipient. Umbilical cords (UCs) are a good source of MSCs because they are abundant, safe, non-invasively harvested after birth and, importantly, they are not encumbered with ethical problems. Here we show that the intravitreal transplant of Wharton´s jelly mesenchymal stem cells isolated from three different human UCs (hWJMSCs) delays axotomy-induced retinal ganglion cell (RGC) loss. In vivo, hWJMSCs secrete anti-inflammatory molecules and trophic factors, the latter alone may account for the elicited neuroprotection. Interestingly, this expression profile differs between naive and injured retinas, suggesting that the environment in which the hWJMSCs are modulates their secretome. Finally, even though the transplant itself is not toxic for RGCs, it is not innocuous as it triggers a transient but massive infiltration of Iba1+cells from the choroid to the retina that alters the retinal structure.